Comparison of the Binding Activities of Some Drugs on α2A, α2B and α2C‐Adrenoceptors and Non‐Adrenergic Imidazoline Sites in the Guinea Pig
暂无分享,去创建一个
Staffan Uhlén | Jarl E. S. Wikberg | J. Wikberg | G. Tiger | R. Muceniece | Ruta Muceniece | Ninfa Rangel | Gunnar Tiger | S. Uhlén | N. Rangel
[1] J. Wikberg,et al. Further Characterization of the Guinea Pig Cerebral Cortex Idazoxan Receptor: Solubilization, Distinction from the Imidazole Site, and Demonstration of Cirazoline as an Idazoxan Receptor‐Selective Drug , 1990, Journal of neurochemistry.
[2] J. Reid,et al. A comparison of the haemodynamic and behavioural effects of moxonidine and clonidine in normotensive subjects. , 1992, British journal of clinical pharmacology.
[3] T. Ishikawa,et al. Binding of [3H]p-aminoclonidine to two sites, α2-adrenoceptors and imidazoline binding sites: distribution of imidazoline binding sites in rat brain , 1990, Brain Research.
[4] J. Wikberg,et al. Medetomidine stereoisomers delineate two closely related subtypes of idazoxan (imidazoline) I-receptors in the guinea pig. , 1991, European journal of pharmacology.
[5] D. Langin,et al. Binding of [3H]idazoxan and of its methoxy derivative [3H] RX821002 in human fat cells: [3H]idazoxan but not [3H] RX821002 labels additional non-alpha 2-adrenergic binding sites. , 1990, Molecular pharmacology.
[6] P. Insel,et al. Are there multiple imidazoline binding sites? , 1989, Trends in pharmacological sciences.
[7] D. Reis,et al. Rilmenidine lowers arterial pressure via imidazole receptors in brainstem C1 area. , 1991, European journal of pharmacology.
[8] J. Wikberg,et al. Rat Spinal Cord α2‐Adrenoceptors are of the α2A‐Subtype: Comparison with α2A‐ and α2B‐Adrenoceptors in Rat Spleen, Cerebral Cortex and Kidney Using 3H‐RX821002 Ligand Binding , 1991 .
[9] D. Reis,et al. Hypotensive action of clonidine analogues correlates with binding affinity at imidazole and not alpha‐2-adrenergic receptors in the rostral ventrolateral medulla , 1988, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.
[10] D. Reis,et al. Effects of clonidine and other imidazole-receptor binding agents on second messenger systems and calcium influx in bovine adrenal chromaffin cells. , 1991, Biochemical pharmacology.
[11] M. Dontenwill,et al. L 2 ‐ FROM THE α2‐ADRENOCEPTORS TO THE IMIDAZOLINE PREFERRING RECEPTORS , 1992 .
[12] Y. Cheng,et al. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. , 1973, Biochemical pharmacology.
[13] C. A. Guyer,et al. An aspartate conserved among G-protein receptors confers allosteric regulation of alpha 2-adrenergic receptors by sodium. , 1990, The Journal of biological chemistry.
[14] D. Reis,et al. Role of imidazole receptors in the vasodepressor response to clonidine analogs in the rostral ventrolateral medulla. , 1990, The Journal of pharmacology and experimental therapeutics.
[15] M. Dontenwill,et al. Evidence for the involvement of imidazoline receptors in the central hypotensive effect of rilmenidine in the rabbit , 1990, British journal of pharmacology.
[16] William R. Pearson,et al. Molecular characterization of α1- and α2-adrenoceptors , 1991 .
[17] D. Langin,et al. [3H]Idazoxan binding at non-α2-adrenoceptors in rabbit adipocyte membranes , 1989 .
[18] A. Parini,et al. Effect of imidazolines on Na+ transport and intracellular pH in renal proximal tubule cells. , 1990, Biochimica et biophysica acta.
[19] D. Bylund,et al. Molecular determinants of the alpha-2D adrenergic receptor subtype. , 1993, Life sciences.
[20] J. Wikberg,et al. Evidence that drug binding to non-adrenergic [3H]-idazoxan binding sites (I-receptors) occurs to interacting or interconvertible affinity forms of the receptor. , 1992, Pharmacology & toxicology.
[21] R. Graham,et al. Characterization of an imidazoline/guanidinium receptive site distinct from the alpha 2-adrenergic receptor. , 1989, The Journal of biological chemistry.
[22] J. Wikberg. High affinity binding of idazoxan to a non-catecholaminergic binding site in the central nervous system: description of a putative idazoxan-receptor. , 1989, Pharmacology & toxicology.
[23] D. Reis,et al. Characterization and visualization of clonidine-sensitive imidazole sites in rat kidney which recognize clonidine-displacing substance. , 1990, American journal of hypertension.
[24] D. Reis,et al. An endogenous substance with clonidine-like properties: selective binding to imidazole sites in the ventrolateral medulla , 1988, Brain Research.
[25] J. Harrison,et al. Pharmacological characterization of rat alpha 2-adrenergic receptors. , 1991, Molecular pharmacology.
[26] F. Gonon,et al. Selectivity of rilmenidine for the nucleus reticularis lateralis, a ventrolateral medullary structure containing imidazoline-preferring receptors. , 1991, European journal of pharmacology.
[27] D. Langin,et al. Discrimination between alpha 2-adrenoceptors and [3H]idazoxan-labelled non-adrenergic sites in rabbit white fat cells. , 1990, European journal of pharmacology.
[28] D. Reis,et al. L 3 ‐ IMIDAZOLINE RECEPTORS IN THE NERVOUS SYSTEM , 1992, Fundamental & clinical pharmacology.
[29] O. H. Lowry,et al. Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.
[30] J. Wikberg,et al. Further evidence for the existence of two forms of alpha 2B-adrenoceptors in rat. , 1993, Pharmacology & toxicology.
[31] M. Dontenwill,et al. The imidazoline preferring receptor: binding studies in bovine, rat and human brainstem. , 1989, European journal of pharmacology.
[32] J. De Keyser,et al. High affinity binding of 3H rauwolscine and 3H RX781094 to alpha 2 adrenergic receptors and non-stereoselective sites in human and rabbit brain cortex membranes. , 1989, Biochemical pharmacology.
[33] J. Huff,et al. [3H]L-657, 743 (MK-912): A new, high affinity, selective radioligand for brain α2-adrenoceptors , 1989 .
[34] M. Dontenwill,et al. New concepts on the central regulation of blood pressure. Alpha 2-adrenoceptors and "imidazoline receptors". , 1989, The American journal of medicine.
[35] D. Reis,et al. Clonidine binds to imidazole binding sites as well as alpha 2-adrenoceptors in the ventrolateral medulla. , 1987, European journal of pharmacology.
[36] J. Wikberg,et al. Delineation of three pharmacological subtypes of α2‐adrenoceptor in the rat kidney , 1991 .
[37] H. Y. Kwa,et al. Characterization of alpha-adrenoceptors participating in the central hypotensive and sedative effects of clonidine using yohimbine, rauwolscine and corynanthine. , 1981, European journal of pharmacology.
[38] J. Wikberg,et al. [3H]‐MK 912 binding delineates two α2‐adrenoceptor subtypes in rat CNS one of which is identical with the cloned pA2d α2‐adrenoceptor , 1992 .
[39] J. Pégorier,et al. Subcellular distribution of imidazoline-guanidinium-receptive sites in human and rabbit liver. Major localization to the mitochondrial outer membrane. , 1991, The Journal of biological chemistry.
[40] J. Reid,et al. Imidazole binding sites in rabbit kidney and forebrain membranes. , 1991, Journal of autonomic pharmacology.
[41] P. Molinoff,et al. International Union of Pharmacology nomenclature of adrenoceptors. , 1994, Pharmacological reviews.
[42] G. Barsh,et al. Cloning of two mouse genes encoding alpha 2-adrenergic receptor subtypes and identification of a single amino acid in the mouse alpha 2-C10 homolog responsible for an interspecies variation in antagonist binding. , 1992, Molecular pharmacology.
[43] D. Atlas,et al. Imidazoline-guanidinium receptive site in renal proximal tubule: asymmetric distribution, regulation by cations and interaction with an endogenous clonidine displacing substance. , 1990, The Journal of pharmacology and experimental therapeutics.
[44] P. Gosse,et al. [Rilmenidine, a new antihypertensive agent in the first line treatment of essential arterial hypertension. Multicenter double-blind study versus atenolol]. , 1991, Presse medicale.
[45] H. Motulsky,et al. [3H]idazoxan and some other alpha 2-adrenergic drugs also bind with high affinity to a nonadrenergic site. , 1989, Molecular pharmacology.
[46] D. Bylund. Subtypes of α1‐ and α2‐adrenergic receptors , 1992 .
[47] J. Wikberg,et al. Delineation of rat kidney α2A- and α2B-adrenoeeptors with [3H]RX821002 radiollgand binding: computer modelling reveals that guanfacine is an α2A-selective compound , 1991 .